Reactivation of Lytic Replication from B Cells Latently Infected with Epstein-Barr Virus Occurs with High S-Phase Cyclin-Dependent Kinase Activity while Inhibiting Cellular DNA Replication
Open Access
- 15 January 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (2) , 851-861
- https://doi.org/10.1128/jvi.77.2.851-861.2003
Abstract
Productive infection and replication of herpesviruses usually occurs in growth-arrested cells, but there has been no direct evidence in the case of Epstein-Barr virus (EBV), since an efficient lytic replication system without external stimuli does not exist for the virus. Expression of the EBV lytic-switch transactivator BZLF1 protein in EBV-negative epithelial tumor cell lines, however, is known to arrest the cell cycle in G 0 /G 1 by induction of the tumor suppressor protein p53 and the cyclin-dependent kinase (CDK) inhibitors p21 WAF-1/CIP-1 and p27 KIP-1 , followed by the accumulation of a hypophosphorylated form of the Rb protein. In order to determine the effect of the onset of lytic viral replication on cellular events in latently EBV-infected B LCLs, a tightly controlled induction system of the EBV lytic-replication program by inducible BZLF1 protein expression was established in B95-8 cells. The induction of lytic replication completely arrested cell cycle progression and cellular DNA replication. Surprisingly, the levels of p53, p21 WAF-1/CIP-1 , and p27 KIP-1 were constant before and after induction of the lytic program, indicating that the cell cycle arrest induced by the lytic program is not mediated through p53 and the CDK inhibitors. Furthermore, although cellular DNA replication was blocked, elevation of cyclin E/A expression and accumulation of hyperphosphorylated forms of Rb protein were observed, a post-G 1 /S phase characteristic of cells. Thus, while the EBV lytic program promoted specific cell cycle-associated activities involved in the progression from G 1 to S phase, it inhibited cellular DNA synthesis. Such cellular conditions appear to especially favor viral lytic replication.Keywords
This publication has 33 references indexed in Scilit:
- Activators of the Epstein-Barr Virus Lytic Program Concomitantly Induce Apoptosis, but Lytic Gene Expression Protects from Cell DeathJournal of Virology, 2001
- Inhibition of Cell Growth and Epstein-Barr Virus Reactivation by CD40 Stimulation in Epstein-Barr Virus-Transformed B CellsViral Immunology, 2000
- Induction of S phase by G1 regulatory factorsFrontiers in Bioscience-Landmark, 1999
- Cyclin/Cdk-Dependent Initiation of DNA Replication in a Human Cell-Free SystemPublished by Elsevier ,1997
- Epstein--Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genomeJournal of General Virology, 1996
- Transcriptional control by E2FSeminars in Cancer Biology, 1995
- Reversal of terminal differentiation and control of DNA replication: Cyclin A and cdk2 specifically localize at subnuclear sites of DNA replicationCell, 1993
- Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virusCell, 1988
- DNA sequence and expression of the B95-8 Epstein—Barr virus genomeNature, 1984
- Cross‐linking of cell surface immunoglobulins induces epstein‐barr virus in burkitt lymphoma linesInternational Journal of Cancer, 1984